Follow-up of excision of cutaneous melanoma: Sentinel node biopsy, lymph node ultrasound or clinical surveillance alone?;Après exérèse d'un mélanome cutané: Ganglion sentinelle, échographie ganglionnaire ou simple surveillance clinique?

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 12, 2005, Pages 941-944

  Machet, L ^a   Vaillant, L ^a   Lorette, G ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; CLINICAL EXAMINATION; EDITORIAL; FOLLOW UP; HUMAN; LYMPH NODE; MELANOMA; POSTOPERATIVE PERIOD; SENTINEL LYMPH NODE BIOPSY; ULTRASOUND;

EID: 31844435373     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(05)79553-3     Document Type: Editorial

References (18)

1. Guitera P, Bourrier P, Basset-Seguin N, Dubertret L. L'échographie devrait devenir l'examen de référence dans la détection de l'atteinte ganglionnaire du mélanome. Ann Dermatol Venereol 2004;131:937-9.
2. Anonyme. Suivi des patients opérés d'un mélanome de stade I. Conférence de consensus. Paris, France, 30 mars 1995. Ann Dermatol Venereol 1995;122:250-391.
3. Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton-Bishop JA, Corrie PG, et al. U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146:7-17.
4. Voit C, Mayer T, Kron M, Schoengen A, Sterry W, Weber L, et al. Efficacity of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 2001;91:2409-16.
5. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic Factors Analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 2001;19:3622-34.
6. Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977;297:627-30.
7. Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87-97.
8. Cascinelli N, Morabito A, Santinami M, Bufalino R, Morabito A. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. Lancet 1998;351:793-6.
9. Lens MB, Dawes M, Goodacre T, Newton-Bishop JA. Elective lymph node dissection in patients with melanoma. Systematic review and meta-analysis of randomized controlled trials. Arch Surg 2002;137:458-61.
10. Morton DL, Thompson JF, Cochran AJ, Elashoff R, Essner R, Glass EG, et al. Interim results of the multicenter selective lymphadenopathy trial (MSLT-1) in clinical Stage I Melanoma. ASCO, Orlando, 15 may 2005. www.asco.org
11. Trost O, Danino AM, Dutronc Y, Dalac S, Lambert D, Malka G. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma (EJSO 2002;28:673-8). Eur J Surg Oncol 2003;29:699.
12. Orfanos CE, Jung EG, Rasner G, Wolff HH, Garbe C. Stellungnahme und empfehlungen der komission malignes melanom der Deutschen Dermatologischen gesellshaft zur diagnostik, Behandlung und nachsorge des malignes melnoms der haut. Hautarzt 1994;45: 285-91.
13. Machet L, Nemeth-Normand F, Giraudeau B, Tiguemounine J, Ayoub J, Alison D, et al. Is ultrasound lymph node examination superior to palpation in melanoma follow-up? A monocentre cohort study of 373 patients. Br J Dermatol Online publication date: 5-Jan-2005 doi: 10.1111/j.1365-2133.2004.06262.x.
14. Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol 2004;5:673-80.
15. Machet L, Perrinaud A, Giraudeau B. Routine lymph node sonography in melanoma follow-up? Lancet Oncol 2005;6:2.
16. Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer 2002;87:151-7.
17. Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, et al. Prospective evaluation of a follow-up schedule in cutanous melanoma patients: recommendations for an effective follow-up stategy. J Clin Oncol 2003;21:520-9.
18. Autier P, Coebergh JW, Boniol M, Dore JF, de Vries E, Eggermont AM. Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated. J Clin Oncol 2003;21:3707.